✦ LIBER ✦

Oral candidosis in patients with advanced cancer

✍ Scribed by Andrew N. Davies; Susan R. Brailsford; David Beighton

Book ID: 113832683
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 108 KB
Volume: 42
Category: Article
ISSN: 1368-8375
DOI: 10.1016/j.oraloncology.2005.11.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral Candidosis in Community-Based Patie

Oral Candidosis in Community-Based Patients with Advanced Cancer

✍ Andrew N. Davies; Susan R. Brailsford; David Beighton; Kate Shorthose; Victoria 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Oral Candida albicans biotypes in chines

Oral Candida albicans biotypes in chinese patients with and without oral candidosis

✍ Y.Y. Xu; L.P. Samaranayake 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Chemoradiation for patients with advance

Chemoradiation for patients with advanced oral cavity cancer

✍ Kerstin M. Stenson; Rangesh Kunnavakkam; Ezra E. W. Cohen; Louis D. Portugal; El 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

## Abstract ## Objectives/Hypothesis: Patients with advanced oral cavity cancer (OCC) typically have not been enrolled in clinical trials utilizing contemporary multimodality strategies. There exist dogmatic expectations of inferior outcome in OCC patients secondary to ineffectiveness of treatment

Challenges of Oral Medications in Patien

Challenges of Oral Medications in Patients With Advanced Breast Cancer

✍ Frances M. Palmieri; Debra L. Barton 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Oral Candidosis and its Role in Immunoco

Oral Candidosis and its Role in Immunocompromised Patients

✍ H. Lode; G. Höffken 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB

Oral doxifluridine plus levoleucovorin i

Oral doxifluridine plus levoleucovorin in elderly patients with advanced breast cancer

✍ Emilio Bajetta; Laura Biganzoli; Carlo Carnaghi; Maria Di Bartolomeo; Ivo Spagno 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

## BACKGROUND. There currently is no agreement regarding the appropriate treatment of elderly patients with advanced breast carcinoma (ABC). Doxifluridine (5-dFUR), a prodrug of 5-fluorouracil, has been found to be effective in this entity, but its use is limited by neurotoxicity and cardiotoxici